Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current

News

Recap: Inovio Pharmaceuticals Q2 Earnings

Author: Benzinga Insights | August 09, 2022 11:50pm

 

Inovio Pharmaceuticals (NASDAQ:INO) reported its Q2 earnings results on Tuesday, August 9, 2022 at 04:05 PM.

Here's what investors need to know about the announcement.

Earnings

Inovio Pharmaceuticals missed estimated earnings by 48.39%, reporting an EPS of $-0.46 versus an estimate of $-0.31.

Revenue was up $511 thousand from the same period last year.

Past Earnings Performance

Last quarter the company missed on EPS by $0.02 which was followed by a 27.31% drop in the share price the next day.

Here's a look at Inovio Pharmaceuticals's past performance:

 

Quarter Q1 2022 Q4 2021 Q3 2021 Q2 2021
EPS Estimate -0.34 -0.32 -0.33 -0.25
EPS Actual -0.36 -0.50 -0.29 -0.39
Revenue Estimate 670K 2.84M 970K 1.21M
Revenue Actual 199K 839K 291K 272K

To track all earnings releases for Inovio Pharmaceuticals visit their earnings calendar here.

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Posted In: INO

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist